Suppr超能文献

衰老与疾病中线粒体完整性的调控

Control of mitochondrial integrity in ageing and disease.

作者信息

Szklarczyk Radek, Nooteboom Marco, Osiewacz Heinz D

机构信息

Centre for Molecular and Biomolecular Informatics, Radboud University Medical Centre, 6500 HB Nijmegen, The Netherlands Department of Clinical Genetics, Unit Clinical Genomics, Maastricht University Medical Centre, 6200 MD Maastricht, The Netherlands

Department of Biochemistry (286), Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, 6500 HB Nijmegen, The Netherlands.

出版信息

Philos Trans R Soc Lond B Biol Sci. 2014 Jul 5;369(1646):20130439. doi: 10.1098/rstb.2013.0439.

Abstract

Various molecular and cellular pathways are active in eukaryotes to control the quality and integrity of mitochondria. These pathways are involved in keeping a 'healthy' population of this essential organelle during the lifetime of the organism. Quality control (QC) systems counteract processes that lead to organellar dysfunction manifesting as degenerative diseases and ageing. We discuss disease- and ageing-related pathways involved in mitochondrial QC: mtDNA repair and reorganization, regeneration of oxidized amino acids, refolding and degradation of severely damaged proteins, degradation of whole mitochondria by mitophagy and finally programmed cell death. The control of the integrity of mtDNA and regulation of its expression is essential to remodel single proteins as well as mitochondrial complexes that determine mitochondrial functions. The redundancy of components, such as proteases, and the hierarchies of the QC raise questions about crosstalk between systems and their precise regulation. The understanding of the underlying mechanisms on the genomic, proteomic, organellar and cellular levels holds the key for the development of interventions for mitochondrial dysfunctions, degenerative processes, ageing and age-related diseases resulting from impairments of mitochondria.

摘要

真核生物中有多种分子和细胞途径来控制线粒体的质量和完整性。这些途径参与在生物体的生命周期中维持这种重要细胞器的“健康”群体。质量控制(QC)系统可对抗导致细胞器功能障碍的过程,这些功能障碍表现为退行性疾病和衰老。我们讨论了线粒体QC中与疾病和衰老相关的途径:线粒体DNA修复和重组、氧化氨基酸的再生、严重受损蛋白质的重折叠和降解、通过线粒体自噬对整个线粒体的降解,以及最终的程序性细胞死亡。线粒体DNA完整性的控制及其表达的调节对于重塑决定线粒体功能的单个蛋白质以及线粒体复合物至关重要。蛋白酶等成分的冗余以及质量控制的层次结构引发了关于系统间相互作用及其精确调节的问题。在基因组、蛋白质组、细胞器和细胞水平上对潜在机制的理解是开发针对线粒体功能障碍、退行性过程、衰老以及由线粒体损伤引起的与年龄相关疾病的干预措施的关键。

相似文献

1
Control of mitochondrial integrity in ageing and disease.衰老与疾病中线粒体完整性的调控
Philos Trans R Soc Lond B Biol Sci. 2014 Jul 5;369(1646):20130439. doi: 10.1098/rstb.2013.0439.
2
Mitochondrial Proteases: Multifaceted Regulators of Mitochondrial Plasticity.线粒体蛋白酶:线粒体可塑性的多面调节因子。
Annu Rev Biochem. 2020 Jun 20;89:501-528. doi: 10.1146/annurev-biochem-062917-012739. Epub 2020 Feb 19.
3
Impaired quality control of mitochondria: aging from a new perspective.线粒体质量控制受损:从新视角看待衰老。
Exp Gerontol. 2010 Aug;45(7-8):503-11. doi: 10.1016/j.exger.2010.03.018. Epub 2010 May 6.
5
Neurodegeneration as a consequence of failed mitochondrial maintenance.神经退行性变是由于线粒体维持失败引起的。
Acta Neuropathol. 2012 Feb;123(2):157-71. doi: 10.1007/s00401-011-0921-0. Epub 2011 Dec 7.
7
Mitochondrial Diseases as Model of Neurodegeneration.线粒体疾病作为神经退行性变的模型
Adv Exp Med Biol. 2017;1007:129-155. doi: 10.1007/978-3-319-60733-7_8.
9
Mechanisms of mitochondria and autophagy crosstalk.线粒体与自噬相互作用的机制。
Cell Cycle. 2011 Dec 1;10(23):4032-8. doi: 10.4161/cc.10.23.18384.
10
Mitochondrial clearance: mechanisms and roles in cellular fitness.线粒体清除:细胞适应性中的机制和作用。
FEBS Lett. 2021 Apr;595(8):1239-1263. doi: 10.1002/1873-3468.14060. Epub 2021 Mar 8.

引用本文的文献

5
Chronic inflammation and the hallmarks of aging.慢性炎症与衰老的特征。
Mol Metab. 2023 Aug;74:101755. doi: 10.1016/j.molmet.2023.101755. Epub 2023 Jun 15.
10
The function of lncRNAs in the pathogenesis of osteoarthritis.长链非编码RNA在骨关节炎发病机制中的作用。
Bone Joint Res. 2021 Feb;10(2):122-133. doi: 10.1302/2046-3758.102.BJR-2020-0228.R1.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验